| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/23/2006 | WO2006002257A3 Pecam-1-related molecules compositions kit of parts and associated methods of use |
| 02/23/2006 | WO2005118835A3 Cell lines and methods for evaluating integrating polynucleotides |
| 02/23/2006 | WO2005111069A3 Morphogenic proteins and stimulatory factors in gene therapy |
| 02/23/2006 | WO2005105986A3 Neural cell differentiation method from es cells |
| 02/23/2006 | WO2005070066A3 Chlorophyllous totipotent cell cultures |
| 02/23/2006 | WO2005004988A3 Compositions and methods relating to novel compounds and targets thereof |
| 02/23/2006 | WO2004065552A3 Cell-based therapies for diabetes mellitus and other glucose intolerant states |
| 02/23/2006 | WO2004001061A3 Antisense modulation of heme oxygenase 1 expression |
| 02/23/2006 | WO2003072732A3 Methods of making hypermutable cells using pmsr homologs |
| 02/23/2006 | WO2003070889A3 Prostate specific genes and the use thereof in design or therapeutics |
| 02/23/2006 | US20060041962 Genes and uses thereof to modulate secondary metabolite biosynthesis |
| 02/23/2006 | US20060041950 Cassava vein mosaic virus promoters nucleic acid sequences and expression vectors |
| 02/23/2006 | US20060041948 Transgenic mice containing chemokine receptor 9A gene disruptions |
| 02/23/2006 | US20060041947 Nessie nucleic acids, polypeptides and mutations, and methods of use thereof |
| 02/23/2006 | US20060041320 Suturable adhesion-preventing membrane |
| 02/23/2006 | US20060041107 Mutants of streptococcal toxin A and methods of use |
| 02/23/2006 | US20060040885 Bioprosthetic heart valves |
| 02/23/2006 | US20060040877 Capable of functioning in Saccharopolyspora spinosa; for controlling insects |
| 02/23/2006 | US20060040392 Identification of a rare undifferentiated cell population from human fetal blood that is capable of self-renewal and has the potential to differentiate into cells representing each of the three embryonic germ layers |
| 02/23/2006 | US20060040389 Purified compositions of stem cell derived differentiating cells |
| 02/23/2006 | US20060040388 Suitable for use as recyclable oxygen carriers, separation and purification vehicles, and bioprocessing media, including fermentation |
| 02/23/2006 | US20060040387 Islet cells from human embryonic stem cells |
| 02/23/2006 | US20060040386 Human hepatic progenitor cells and methods of use thereof |
| 02/23/2006 | US20060040385 Cultured human pancreatic islets, and uses thereof |
| 02/23/2006 | US20060040384 Serum free cultivation of primate embryonic stem cells |
| 02/23/2006 | US20060040383 Primate embryonic stem cells |
| 02/23/2006 | US20060040363 Human antibodies derived from immunized xenomice |
| 02/23/2006 | US20060040361 Protective antigens and vaccines for the control of multi species tick infestations |
| 02/23/2006 | US20060040360 Adipocyte complement related protein homolog zacrp7 |
| 02/23/2006 | US20060040359 Oxidation-reduction sensitive green fluorescent protein variants |
| 02/23/2006 | US20060040356 Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins |
| 02/23/2006 | US20060040354 Novel polyadenylation signal for use in expression vectors |
| 02/23/2006 | US20060040348 Methods for producing and purifying recombinant alpha-L-iduronidase |
| 02/23/2006 | US20060040347 Use of triplex structure DNA in transferring nucleotide sequences |
| 02/23/2006 | US20060040325 Integrin antagonists with enhanced antibody dependent cell-mediated cytoxicity activity |
| 02/23/2006 | US20060040323 Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis |
| 02/23/2006 | US20060040321 Orphan receptor TLX and uses therefor |
| 02/23/2006 | US20060040313 Human chemokine beta-9 |
| 02/23/2006 | US20060040307 A recombinant human telomerase reverse transcriptase (hTRT) protein; drug screening for antiproliferative agents that inhibit hTRT activity; cancer diagnosis and prognosis; anticarcinogenic agents |
| 02/23/2006 | US20060040298 Rhesus monkey NURR1 nuclear receptor |
| 02/23/2006 | US20060040265 Regulation of novel human asparagine-hydroxylases |
| 02/23/2006 | US20060040255 Cell line designated KT-1 established from tongue epithelial and use thereof |
| 02/23/2006 | US20060040252 Prognostic tests for development of dermal stretch marks and implications for the preventive treatment thereof |
| 02/23/2006 | US20060040250 G-protein coupled receptor fusion protein is modified to include one or more sets of serine/threonine clusters, which enhance binding of such GPCR to arrestin; screening for GPCR ligands, agonists and/or antagonists |
| 02/23/2006 | US20060040249 Screening method involving transfected primary cells |
| 02/23/2006 | US20060039993 Retinal cell grafts and instrument for implanting |
| 02/23/2006 | US20060039928 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/23/2006 | US20060039922 Streptococcal heat shock proteins of the Hsp60 family |
| 02/23/2006 | US20060039918 Stress proteins and peptides and methods of use thereof |
| 02/23/2006 | US20060039915 P-cadherin as a target for anti-cancer therapy |
| 02/23/2006 | US20060039909 Human CD28 specific monoclonal antibodies for antigen-non-specific activation of T-lymphocytes |
| 02/23/2006 | US20060039906 Humanized antibodies that sequester abeta peptide |
| 02/23/2006 | US20060039897 transforming a stinging cell or stinging cell progenitor with a polynucleotide encoding a therapeutic, cosmetic or diagnostic agent to thereby generate at least one stinging cell expressing therapeutic, cosmetic or diagnostic agent in the stinging cell (derived from Cnidaria, Dinoflagelleaa) |
| 02/23/2006 | US20060039896 Augmentation and repair of age-related soft tissue defects |
| 02/23/2006 | US20060039895 Ex-vivo rescue of hematopoietic stem cells after lethal irradiation |
| 02/23/2006 | US20060039860 Delivering a biopolymer to a cell by forming a complex of a biologically active polymer and a cyclic amidinium-containing compound and associating the complex with the cell |
| 02/23/2006 | DE20023745U1 Method of modulating expression of an endogenous cellular gene in a cell to prevent gene activation or prevent repression of gene expression comprising contacting a target sequence with a zinc finger protein |
| 02/23/2006 | DE102004039537A1 Vernetzte Kollagenmatrix zur Herstellung eines Hautäquivalentes Cross-linked collagen matrix for the preparation of a skin equivalent |
| 02/23/2006 | CA2579764A1 Methods of regulating differentiation and treating of multiple myeloma |
| 02/23/2006 | CA2577660A1 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 02/23/2006 | CA2577447A1 Isolation of stem/progenitor cells from amniotic membrane of umbilical cord |
| 02/23/2006 | CA2577250A1 Cytochrome p450 induction assay |
| 02/23/2006 | CA2576932A1 Organogenesis from dissociated cells |
| 02/23/2006 | CA2576872A1 Compositions and methods for self-renewal and differentiation in human embryonic stem cells |
| 02/23/2006 | CA2575689A1 Tr1 cells for use in atherosclerosis |
| 02/23/2006 | CA2575368A1 Cloning and expression of recombinant adhesive protein mefp-1 of the blue mussel, mytilus edulis |
| 02/23/2006 | CA2574186A1 Isolation of endothelial progenitor cell subsets and methods for their use |
| 02/23/2006 | CA2573192A1 Variant fc regions |
| 02/23/2006 | CA2569235A1 Anti-ghrelin antibodies |
| 02/22/2006 | EP1627919A1 An infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof |
| 02/22/2006 | EP1627914A2 Methods and devices for the long-term culture of hematopoietic progenitor cells |
| 02/22/2006 | EP1627913A1 Mesenchymal stem cell |
| 02/22/2006 | EP1627912A1 Preparation of endodermal stem cells |
| 02/22/2006 | EP1627911A1 Washing apparatus |
| 02/22/2006 | EP1627910A1 Apparatus for culturing organism and culture method |
| 02/22/2006 | EP1627563A1 Means and methods for producing a stabilized cell of interest |
| 02/22/2006 | EP1627071A2 Multicellular compositions of pluripotent human embryonic stem cells and cancer cells |
| 02/22/2006 | EP1627068A2 Compositions and methods for altering biosynthesis of taxanes and taxane-related compounds |
| 02/22/2006 | EP1627055A2 Novel uses of ppar modulators and professional apcs manipulated by the same |
| 02/22/2006 | EP1627054A1 Allogeneic cell therapy: mirror effect |
| 02/22/2006 | EP1627053A1 Method for increasing the yield of proliferating primary keratinocytes |
| 02/22/2006 | EP1627051A2 Regulation of acheron expression |
| 02/22/2006 | EP1627047A2 Methods for facilitating recovery of functions of endogenous or implanted or transplanted stem cells using high molecular weight hyaluronic acid |
| 02/22/2006 | EP1626993A2 Cd20-specific antibodies and methods of employing same |
| 02/22/2006 | EP1626992A1 Production of recombinant igm in per.c6 cells |
| 02/22/2006 | EP1626981A2 Dipeptidyl-peptidase protected proteins |
| 02/22/2006 | EP1626623A2 Method for cloning in the rat by nuclear transfer |
| 02/22/2006 | EP1509595A4 Dendritic cell isolation methods |
| 02/22/2006 | EP1436402B1 Coffee plant with reduced alpha-d-galactosidase activity |
| 02/22/2006 | EP1402005A4 A method of purification of cells |
| 02/22/2006 | EP1244803B1 Veto cells effective in preventing graft rejection and devoid of graft versus host potential |
| 02/22/2006 | EP1121431B1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 02/22/2006 | EP1109564B1 Method for removal of hiv and other viruses from blood |
| 02/22/2006 | EP1062336B1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 02/22/2006 | EP1040185B1 Neural precursor cells, method for the production and use thereof in neural defect therapy |
| 02/22/2006 | EP1000161B1 Anticoagulant fusion protein anchored to cell membrane |
| 02/22/2006 | EP0932682B1 BACILLUS THURINGIENSIS CryET29 COMPOSITIONS TOXIC TO COLEOPTERAN INSECTS AND CTENOCEPHALIDES SPP |
| 02/22/2006 | EP0907723B1 Enzyme composition for tissue dissociation |
| 02/22/2006 | EP0805871B2 Anti-cd30 antibodies preventing proteolytic cleavage and release of membrane-bound cd30 antigen |
| 02/22/2006 | EP0729297B1 Hepatoblasts and method of isolating same |